- Home
- ADMA vs LBTYB Comparison
ADMA vs LBTYB Comparison
Compare ADMA & LBTYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- LBTYB
- Stock Information
- Founded
- ADMA 2004
- LBTYB 2004
- Country
- ADMA United States
- LBTYB Bermuda
- Employees
- ADMA N/A
- LBTYB N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- LBTYB Cable & Other Pay Television Services
- Sector
- ADMA Health Care
- LBTYB Telecommunications
- Exchange
- ADMA Nasdaq
- LBTYB Nasdaq
- Market Cap
- ADMA 5.1B
- LBTYB 4.2B
- IPO Year
- ADMA N/A
- LBTYB N/A
- Fundamental
- Price
- ADMA $15.69
- LBTYB $11.61
- Analyst Decision
- ADMA Strong Buy
- LBTYB
- Analyst Count
- ADMA 3
- LBTYB 0
- Target Price
- ADMA $27.67
- LBTYB N/A
- AVG Volume (30 Days)
- ADMA 2.9M
- LBTYB 205.0
- Earning Date
- ADMA 11-06-2025
- LBTYB 01-01-0001
- Dividend Yield
- ADMA N/A
- LBTYB N/A
- EPS Growth
- ADMA 469.09
- LBTYB N/A
- EPS
- ADMA 0.85
- LBTYB N/A
- Revenue
- ADMA $474,174,000.00
- LBTYB $4,633,000,000.00
- Revenue This Year
- ADMA $21.08
- LBTYB $10.21
- Revenue Next Year
- ADMA $25.98
- LBTYB $1.04
- P/E Ratio
- ADMA $18.53
- LBTYB N/A
- Revenue Growth
- ADMA 43.58
- LBTYB 81.79
- 52 Week Low
- ADMA $13.50
- LBTYB $9.15
- 52 Week High
- ADMA $25.67
- LBTYB $21.90
- Technical
- Relative Strength Index (RSI)
- ADMA 36.86
- LBTYB 45.96
- Support Level
- ADMA $15.14
- LBTYB $11.47
- Resistance Level
- ADMA $17.17
- LBTYB $11.04
- Average True Range (ATR)
- ADMA 0.55
- LBTYB 0.00
- MACD
- ADMA -0.12
- LBTYB -0.08
- Stochastic Oscillator
- ADMA 22.59
- LBTYB 18.67
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About LBTYB Liberty Global Ltd. Class B
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.